Trial Profile
Multi-center, Investigator Initiated Phase 1 Study of MAGE-A4 Specific TCR Gene Transferred T Lymphocytes With Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs TBI 1201 (Primary) ; Cyclophosphamide; Fludarabine
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 13 Jun 2021 Status changed from active, no longer recruiting to completed.
- 19 Oct 2018 Planned End Date changed from 30 Jun 2018 to 31 Mar 2019.
- 19 Oct 2018 Status changed from recruiting to active, no longer recruiting.